Abstract
SARS-CoV-2 IgG screening of 1,000 antenatal serum samples in the Oxford area, United Kingdom, between 14 April and 15 June 2020, yielded a 5.3% seroprevalence, mirroring contemporaneous regional data. Among the 53 positive samples, 39 showed in vitro neutralisation activity, correlating with IgG titre (Pearson's correlation p<0.0001). While SARS-CoV-2 seroprevalence in pregnancy cohorts could potentially inform population surveillance, clinical correlates of infection and immunity in pregnancy, and antenatal epidemiology evolution over time need further study.
| Original language | English |
|---|---|
| Journal | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin |
| Volume | 25 |
| Issue number | 42 |
| DOIs | |
| Publication status | Published - Oct 2020 |
Research Groups and Themes
- Covid19
Keywords
- Adolescent
- Adult
- Antibodies, Neutralizing/blood
- Antibodies, Viral/blood
- Betacoronavirus/immunology
- COVID-19
- Cohort Studies
- Coronavirus Infections/blood
- England/epidemiology
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Immunoglobulin G/blood
- Middle Aged
- Pandemics
- Pneumonia, Viral/blood
- Population Surveillance
- Pregnancy
- Pregnancy Complications, Infectious/blood
- Pregnancy Trimester, First/blood
- Prenatal Diagnosis
- Prevalence
- SARS-CoV-2
- Seroepidemiologic Studies
- Single-Blind Method
- Young Adult